Literature DB >> 26893383

Structural Basis of the Interaction between Tuberous Sclerosis Complex 1 (TSC1) and Tre2-Bub2-Cdc16 Domain Family Member 7 (TBC1D7).

Jiayue Qin1, Zhizhi Wang2, Marianne Hoogeveen-Westerveld3, Guobo Shen2, Weimin Gong4, Mark Nellist5, Wenqing Xu6.   

Abstract

Mutations in TSC1 or TSC2 cause tuberous sclerosis complex (TSC), an autosomal dominant disorder characterized by the occurrence of benign tumors in various vital organs and tissues. TSC1 and TSC2, the TSC1 and TSC2 gene products, form the TSC protein complex that senses specific cellular growth conditions to control mTORC1 signaling. TBC1D7 is the third subunit of the TSC complex, and helps to stabilize the TSC1-TSC2 complex through its direct interaction with TSC1. Homozygous inactivation of TBC1D7 causes intellectual disability and megaencephaly. Here we report the crystal structure of a TSC1-TBC1D7 complex and biochemical characterization of the TSC1-TBC1D7 interaction. TBC1D7 interacts with the C-terminal region of the predicted coiled-coil domain of TSC1. The TSC1-TBC1D7 interface is largely hydrophobic, involving the α4 helix of TBC1D7. Each TBC1D7 molecule interacts simultaneously with two parallel TSC1 helices from two TSC1 molecules, suggesting that TBC1D7 may stabilize the TSC complex by tethering the C-terminal ends of two TSC1 coiled-coils.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  TBC1D7; TSC1; crystal structure; isothermal titration calorimetry (ITC); mTOR complex (mTORC); protein complex; tuberous sclerosis complex (TSC)

Mesh:

Substances:

Year:  2016        PMID: 26893383      PMCID: PMC4861430          DOI: 10.1074/jbc.M115.701870

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner.

Authors:  Ariel F Castro; John F Rebhun; Geoffrey J Clark; Lawrence A Quilliam
Journal:  J Biol Chem       Date:  2003-07-03       Impact factor: 5.157

2.  Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.

Authors:  Ken Inoki; Yong Li; Tian Xu; Kun-Liang Guan
Journal:  Genes Dev       Date:  2003-07-17       Impact factor: 11.361

Review 3.  Long coiled-coil proteins and membrane traffic.

Authors:  Alison K Gillingham; Sean Munro
Journal:  Biochim Biophys Acta       Date:  2003-08-18

4.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

Review 5.  Tuberous sclerosis complex: a review of neurological aspects.

Authors:  Paolo Curatolo; Magda Verdecchia; Roberta Bombardieri
Journal:  Eur J Paediatr Neurol       Date:  2002       Impact factor: 3.140

Review 6.  Dysregulation of the TSC-mTOR pathway in human disease.

Authors:  Ken Inoki; Michael N Corradetti; Kun-Liang Guan
Journal:  Nat Genet       Date:  2005-01       Impact factor: 38.330

7.  Distinct effects of single amino-acid changes to tuberin on the function of the tuberin-hamartin complex.

Authors:  Mark Nellist; Ozgur Sancak; Miriam A Goedbloed; Christan Rohe; Diana van Netten; Karin Mayer; Aimee Tucker-Williams; Ans M W van den Ouweland; Dicky J J Halley
Journal:  Eur J Hum Genet       Date:  2005-01       Impact factor: 4.246

8.  Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins.

Authors:  Yong Zhang; Xinsheng Gao; Leslie J Saucedo; Binggen Ru; Bruce A Edgar; Duojia Pan
Journal:  Nat Cell Biol       Date:  2003-06       Impact factor: 28.824

9.  Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2.

Authors:  Attila Garami; Fried J T Zwartkruis; Takahiro Nobukuni; Manel Joaquin; Marta Roccio; Hugo Stocker; Sara C Kozma; Ernst Hafen; Johannes L Bos; George Thomas
Journal:  Mol Cell       Date:  2003-06       Impact factor: 17.970

10.  Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.

Authors:  Andrew R Tee; Brendan D Manning; Philippe P Roux; Lewis C Cantley; John Blenis
Journal:  Curr Biol       Date:  2003-08-05       Impact factor: 10.834

View more
  12 in total

1.  Structure of the Tuberous Sclerosis Complex 2 (TSC2) N Terminus Provides Insight into Complex Assembly and Tuberous Sclerosis Pathogenesis.

Authors:  Reinhard Zech; Stephan Kiontke; Uwe Mueller; Andrea Oeckinghaus; Daniel Kümmel
Journal:  J Biol Chem       Date:  2016-08-04       Impact factor: 5.157

2.  Radiobiological Characterization of Tuberous Sclerosis: a Delay in the Nucleo-Shuttling of ATM May Be Responsible for Radiosensitivity.

Authors:  Mélanie L Ferlazzo; Mohamed Kheir Eddine Bach-Tobdji; Amar Djerad; Laurène Sonzogni; Clément Devic; Adeline Granzotto; Larry Bodgi; Jean-Thomas Bachelet; Assia Djefal-Kerrar; Christophe Hennequin; Nicolas Foray
Journal:  Mol Neurobiol       Date:  2017-08-07       Impact factor: 5.590

3.  The tuberous sclerosis complex subunit TBC1D7 is stabilized by Akt phosphorylation-mediated 14-3-3 binding.

Authors:  James P Madigan; Feng Hou; Linlei Ye; Jicheng Hu; Aiping Dong; Wolfram Tempel; Marielle E Yohe; Paul A Randazzo; Lisa M Miller Jenkins; Michael M Gottesman; Yufeng Tong
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

4.  Molecular genetic diagnostics of tuberous sclerosis complex in Bulgaria: six novel mutations in the TSC1 and TSC2 genes.

Authors:  M Glushkova; V Bojinova; M Koleva; P Dimova; M Bojidarova; I Litvinenko; T Todorov; E Iluca; C Calusaru; E Neagu; D Craiu; V Mitev; A Todorova
Journal:  J Genet       Date:  2018-06       Impact factor: 1.166

5.  dTBC1D7 regulates systemic growth independently of TSC through insulin signaling.

Authors:  Suxia Ren; Zengyi Huang; Yuqiang Jiang; Tao Wang
Journal:  J Cell Biol       Date:  2017-11-29       Impact factor: 10.539

6.  Structural insights into TSC complex assembly and GAP activity on Rheb.

Authors:  Huirong Yang; Zishuo Yu; Xizi Chen; Jiabei Li; Ningning Li; Jiaxuan Cheng; Ning Gao; Hai-Xin Yuan; Dan Ye; Kun-Liang Guan; Yanhui Xu
Journal:  Nat Commun       Date:  2021-01-12       Impact factor: 14.919

7.  Architecture of the Tuberous Sclerosis Protein Complex.

Authors:  Kailash Ramlaul; Wencheng Fu; Hua Li; Natàlia de Martin Garrido; Lin He; Manjari Trivedi; Wei Cui; Christopher H S Aylett; Geng Wu
Journal:  J Mol Biol       Date:  2020-12-08       Impact factor: 5.469

8.  Phosphorylation of TSC2 by PKC-δ reveals a novel signaling pathway that couples protein synthesis to mTORC1 activity.

Authors:  Jun Zhan; Raghu K Chitta; Frank C Harwood; Gerard C Grosveld
Journal:  Mol Cell Biochem       Date:  2019-01-25       Impact factor: 3.396

9.  Signal integration in the (m)TORC1 growth pathway.

Authors:  Kailash Ramlaul; Christopher H S Aylett
Journal:  Front Biol (Beijing)       Date:  2018-07-25

10.  Molecular analysis of TSC1 and TSC2 genes and phenotypic correlations in Brazilian families with tuberous sclerosis.

Authors:  Clévia Rosset; Filippo Vairo; Isabel Cristina Bandeira; Rudinei Luis Correia; Fernanda Veiga de Goes; Raquel Tavares Boy da Silva; Larissa Souza Mario Bueno; Mireille Caroline Silva de Miranda Gomes; Henrique de Campos Reis Galvão; João I C F Neri; Maria Isabel Achatz; Cristina Brinckmann Oliveira Netto; Patricia Ashton-Prolla
Journal:  PLoS One       Date:  2017-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.